Toggle Dropdown
Groups
Announcements
Projects
News & Events
Welcome guest
Log in
Friends
Loading
Loading...
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2304753
0
0
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma | NEJM - nejm.org
10/21/23 at 5:45am
Organization
nejm.org
Author
nejm.org
13 words
0
Comments
Business & Industrial
Tebentafusp
Metastatic Uveal Melanoma
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...